Established anticonvulsants and treatment of refractory epilepsy.
about
Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA(A) Receptor Modulators?Safety of long-term lamotrigine in epilepsy.Childhood secondary (symptomatic) epilepsy, seizure control, and intellectual handicap in a nontropical region of South Africa.A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative GroupDrug utilization pattern of antiepileptic drugs and traditional Chinese medicines in a general hospital in Taiwan - a pharmaco-epidemiologic study.Double dummy comparison between once and twice daily dosing with modified-release carbamazepine in epileptic patientsMonotherapy with conventional and controlled-release carbamazepine: a double-blind, double-dummy comparison in epileptic patientsDrug interactions in epilepsy.Neurology.Clinical management of brain metastasis.Randomized controlled study on the use of multiple-dose activated charcoal in patients with supratherapeutic phenytoin levels.Comparison of equations for predicting bound serum concentrations of carbamazepine and carbamazepine-10, 11-epoxide after polytherapy in patients with epilepsy.The problem of intractability: the continuing need for new medical therapies in epilepsy.Synthesis, anticonvulsant and neurotoxicity evaluation of some new pyrimidine-5-carbonitrile derivatives.Safety of topiramate: adverse events and relationships to dosing.No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.Dihydropyridine calcium antagonists in mice: blood and brain pharmacokinetics and efficacy against pentylenetetrazol seizures.Serum protein binding kinetics of phenytoin in monotherapy patients.Management of seizures in the elderly: a survey of UK geriatricians.
P2860
Q21296639-299A0C89-4CA9-47A7-9F48-AF4952BE6606Q33502405-CFC0C18E-765C-4B86-A929-30A5E22AC132Q33712144-9D0B3BE1-9382-4BC3-93D6-5C728F6B4AA1Q33732579-C0B822F3-5528-4538-B6E4-A7F4718FF15EQ33940453-1D42B037-9BA1-4C16-A8B0-4A4F38108676Q34345745-0A1B4136-CE9B-409B-AEBE-F739865A8819Q34358589-48754CAB-A69B-4D9C-8510-B80F8163D6A3Q36379126-A51E2F76-BA28-4D05-A6B3-A97313F13B29Q36681764-F8152A10-F31D-4525-8087-2257AA5911AAQ36896269-9EB3D85E-D203-4158-AFFE-3682763C47C9Q40057073-50D30BF0-792D-4CA2-A5CF-DB66F2E9FD84Q40949599-5EB233AF-4A06-421A-83C9-BC94A73C42FBQ41760373-80092C18-E082-489D-8D6D-96E2F37F3B2CQ42556932-1D25A60B-E6BA-429C-A376-90FCEEAECE06Q42630678-9BEEA26F-2876-41D1-954F-7339B7291CE9Q45929957-E7D3181A-E6FF-4F1C-9FF9-01F9A5E27133Q48458542-8DB4C713-4AAE-4D22-9863-FC4DA4BC00CBQ52228230-393EEF93-D1A5-4F89-BD0A-DED664C6ADFEQ55362845-4DF5A974-74AF-49CC-BEA3-865C6CC699DA
P2860
Established anticonvulsants and treatment of refractory epilepsy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Established anticonvulsants and treatment of refractory epilepsy.
@en
Established anticonvulsants and treatment of refractory epilepsy.
@nl
type
label
Established anticonvulsants and treatment of refractory epilepsy.
@en
Established anticonvulsants and treatment of refractory epilepsy.
@nl
prefLabel
Established anticonvulsants and treatment of refractory epilepsy.
@en
Established anticonvulsants and treatment of refractory epilepsy.
@nl
P1433
P1476
Established anticonvulsants and treatment of refractory epilepsy.
@en
P2093
M J Brodie
P304
P356
10.1016/0140-6736(90)91886-F
P407
P577
1990-08-01T00:00:00Z